Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Tarquin4on Aug 08, 2017 10:32am

143 Views

Post# 26555897

RE:Way to go TLT!! Now get the stock price up!!!!!

The price will go up when Merck offers $50 billion for TLT. From $.50 to $500 a share--must be a record. Yeah right.

I predict TLT will be bought out for $5-$10 a share within 12 months. Roger & Co. will accept.

But hey I hope the dreamers are right. I'll be very rich if they are.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec